Avoid the stress of overpaying for a stock or missing an opportunity by using the right tools and insights to evaluate 111, Inc. before investing.

In this article, we go over a few key elements for understanding 111, Inc.’s stock price such as:

• 111, Inc.’s current stock price and volume
• Why 111, Inc.’s stock price changed recently
• Upgrades and downgrades for YI from analysts
• YI’s stock price momentum as measured by its relative strength

About 111, Inc. (YI)

Before we jump into 111, Inc.’s stock price, history, target price and what caused it to recently rise, let’s take a look at some background.

111, Inc., together with its subsidiaries, operates an integrated online and offline platform in the healthcare market in the People's Republic of China. It operates through two segments, B2C and B2B. The company offers supply chain integration services that help pharmaceutical companies manage products through online and offline channels; product promotion, customer analytics, patient education, and brand awareness services; and marketing and channel data services. It also provides 1 Pharmacy online wholesale pharmacy that offers pharmaceutical and other health and wellness products; and 1 Medicine Marketplace online retail pharmacy that provides pharmaceutical products and other merchandise. In addition, the company offers online loan application services; cloud-based inventory management services; smart procurement services, which collect pharmacies’ historical purchase orders and inventory data; and Hawkeye automated salesforce tool, as well as online consultation, e-prescription, and data services. Further, its pharmacies provide drugs, including prescription and over-the-counter drugs comprising Western and Chinese medicines; nutritional supplements, such as vitamins and dietary products; contact lenses; medical supplies and devices that consists of bandages and thermometers; and personal care products that include skin care, birth control, sexual wellness, and baby products. Additionally, the company offers research and development, and consulting services; warehousing, procurement, and logistics services; and software development and information technology support services. It serves pharmacies, pharmaceutical companies, medical professionals, and marketplace sellers. The company was formerly known as New Peak Group and changed its name to 111, Inc. in April 2018. 111, Inc. was founded in 2010 and is headquartered in Shanghai, the People's Republic of China.

Want to learn more about 111, Inc.’s stock? Click the button below to subscribe to A+ Investor and get access to everything you need to know about 111, Inc..

111, Inc.’s Stock Price as of Market Close

As of March 31, 2026, 3:59 PM, CST, 111, Inc.’s stock price was $6.520.

111, Inc. is up 1.4% from its previous closing price of $6.430.

During the last market session, 111, Inc.’s stock traded between $6.275 and $6.650. Currently, there are approximately 1.22 million shares outstanding for 111, Inc..

111, Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its overall valuation.

111, Inc. Stock Price History

111, Inc.’s (YI) price is currently down 17.57% so far this month.

During the month of March, 111, Inc.’s stock price has reached a high of $8.000 and a low of $6.020.

Over the last year, 111, Inc. has hit prices as high as $11.170 and as low as $2.480. Year to date, 111, Inc.’s stock is up 154.69%.

Sign Up to Receive a Free Special Report Showing How A+ Grades Can Help You Make Smarter Investment Decisions

What Caused 111, Inc. Stock’s Price to Rise?

Stock prices are primarily based on seller supply and buyer demand. But have you ever wondered about what other factors affect a stock's price?

When an analyst changes their opinion of a stock by upgrading or downgrading their rating, it often leads to a sudden stock price adjustment. As of March 31, 2026, there were analysts who downgraded 111, Inc.’s stock and analysts who upgraded over the last month.

Additionally, you'll want to evaluate 111, Inc.’s financial health and valuation. Investors can use AAII's Value Grade, which combines six key valuation metrics like P/E and P/S ratios for a comprehensive analysis to conduct analysis on 111, Inc.’s valuation and financial health. This approach mitigates the limitations of single-metric evaluations.

111, Inc.’s current valuation based on AAII’s Value Grade is a D, which means it is considered to be Expensive.

Learn how to evaluate stocks with AAII Grades and Scores with A+ Investor today.

Lastly, news and media coverage as well as recent press reports about the company or its industry may cause stock prices to fluctuate. You can check out the most recent news articles about 111, Inc. (YI) by visiting AAII Stock Evaluator.

Relative Price Strength of 111, Inc.

Relative price strength measures a stock's performance against the market, helping investors identify stocks that are outperforming benchmarks.

For AAII’s Momentum Grade, a weighted relative price strength is calculated. Follow this link to learn more about the Momentum Grade.

As of March 31, 2026, 111, Inc. has a weighted four-quarter relative price strength of 40.93%, which translates to a Momentum Score of 96 and is considered to be Very Strong.

Want to learn more about how 111, Inc. is graded based on AAII’s composite scores for value, growth, quality and earnings estimate revisions? Subscribe to A+ Investor today.

111, Inc. Stock Price: Bottom Line

As of March 31, 2026, 111, Inc.’s stock price is $6.520, which is up 1.4% from its previous closing price.

AAII advises against making stock decisions based solely on price or past returns. Instead, consider a variety of metrics, fundamentals, and analytics to evaluate a stock like 111, Inc. stock prices are influenced by market supply and demand and offer just a snapshot of a company's overall health.

Subscribing to AAII's A+ Investor provides access to comprehensive analytics and insights for confident investing.